We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PREMIER Biosoft International releases PrimerPlex
Product News

PREMIER Biosoft International releases PrimerPlex

PREMIER Biosoft International releases PrimerPlex
Product News

PREMIER Biosoft International releases PrimerPlex


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "PREMIER Biosoft International releases PrimerPlex"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PREMIER Biosoft International has announced the release of their new product, PrimerPlex. PrimerPlex designs custom oligos for rapid and high-throughput detection of nucleic acid sequences for Luminex 100, Luminex 200 and Bio-Plex Suspension Array systems. The systems are based on Luminex's liquid bead array based xMAP® technology. The major advantage of xMAP® technology is its ability to detect up to 100 sequences in a single reaction.

PrimerPlex will enable users to design custom Capture Probes for the bead arrays based detection system and Allele Specific Primer Extension (ASPE) assays. PrimerPlex is a valuable tool for researchers working on drug screening and validation, gene expression profiling, genotyping, autoimmune and infectious diseases.

"PrimerPlex is the only software product available that supports oligo design for the technology offered by Luminex Corporation. PrimerPlex is a powerful tool for suspension array users to design highly specific and successful multiplex assays.” commented Kay Brown, V.P. Business Development and Marketing.

Advertisement